Aging
Navigate
Submit an Article
Research Paper|Volume 15, Issue 15|pp. 7781–7793
The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)
Back to articleFigure 3(3 of 7)
100%
Figure 3
Figure 3.Kaplan-Meier curve for time to tumor progression for gliomas with different IDH status. The PFS of patients with IDH mutation was longer than that of IDH-wild type patients.